Synapse - David Spriggs

Search Within

David R Spriggs

Results (26)

Survival in epithelial ovarian cancer: A multivariate analysis incorporating BRCA mutation status and platinum sensitivity

Journal Article

Gallagher, D. J.; Konner, J. A.; Bell-Mcguinn, K. M.; Bhatia, J.; Sabbatini, P.; Aghajanian, C. A.; Offit, K.; Barakat, R. R.; Spriggs, D. R.; Kauff, N. D.
Annals of Oncology (2011)

Fulltext@MSK | Save

Consolidation strategies in ovarian cancer: Observations for future clinical trials

Journal Article

Sabbatini, P.; Spriggs, D.; Aghajanian, C.; Hensley, M.; Tew, W.; Konner, J.; Bell-Mcguinn, K.; Juretzka, M.; Iasonos, A.
Gynecologic Oncology (2010)

Fulltext@MSK | Save

Intraperitoneal chemotherapy (IPC) in older women with epithelial ovarian cancer (EOC)

Meeting Abstract

Tew, W. P.; O'Cearbhaill, R.; Zhou, Q.; Thaler, H.; Konner, J.; Hensley, M. L.; Sabbatini, P.; Spriggs, D.; Aghajanian, C.; Lichtman, S. M.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel, IP cisplatin, and IV bevacizumab as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer

Meeting Abstract

Konner, J. A.; Grabon, D.; Pezzulli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Bell-McGuinn, K.; Tew, W.; Spriggs, D.; Aghajanian, C.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study

Journal Article

Hensley, M. L.; Ishill, N.; Soslow, R.; Larkin, J.; Abu Rustum, N.; Sabbatini, P.; Konner, J.; Tew, W.; Spriggs, D.; Aghajanian, C. A.
Gynecologic Oncology (2009)

Fulltext@MSK | Save

Survival benefit for BRCA-associated epithelial ovarian cancer (OC) is not explained by primary platinum sensitivity alone

Meeting Abstract

Konner, J. A.; Gallagher, D. J.; Bell-McGuinn, K. M.; Hansen, J.; Kosarin, K.; Aghajanian, C. A.; Offit, K.; Barakat, R. R.; Spriggs, D. R.; Kauff, N. D.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

The safety and efficacy of bevacizumab therapy in recurrent ovarian carcinoma

Meeting Abstract

Diaz, J. P.; Leitao, M. M. Jr; Konner, J. A.; Sabbatini, P.; Hensley, M. L.; Chi, D. S.; Spriggs, D. R.; Barakat, R. R.; Aghajanian, C. A.; Tew, W. P.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer

Journal Article

Konner, J.; Schilder, R. J.; DeRosa, F. A.; Gerst, S. R.; Tew, W. P.; Sabbatini, P. J.; Hensley, M. L.; Spriggs, D. R.; Aghajanian, C. A.
Gynecologic Oncology (2008)

Fulltext@MSK | Save

A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel (Tax), IP cisplatin (Cis), and IV bevacizumab (Bev) as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer

Meeting Abstract

Konner, J. A.; Fallon, K.; Pezzuli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Chiang, A.; Tew, W.; Spriggs, D.; Aghajanian, C.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Phase I trial of PTK787/ZK222584 (PTK/ZK) in combination with carboplatin (C) and paclitaxel (T) in platinum-sensitive recurrent epithelial ovarian (EOC), fallopian tube (FT), or primary peritoneal (PPC) cancers

Meeting Abstract

Juretzka, M. M.; Aghajanian, C.; Hensley, M. L.; Tew, W. P.; Spriggs, D.; Konner, J.; Chiang, A. C.; Pezzulli, S.; Kim, M.; Sabbatini, P.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save